SANUWAVE Health (SNWV) Non-Current Deffered Revenue (2018 - 2026)
SANUWAVE Health's (SNWV) quarterly Non-Current Deffered Revenue came in at $676000.0 in Q1 2026, up 111.91% year-on-year from $319000.0 in Q1 2025, and down 3.57% on a QoQ basis from $701000.0 in Q4 2025.
SANUWAVE Health (SNWV) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has 9 years of Non-Current Deffered Revenue data on file, last reported at $676000.0 in Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue rose 111.91% year-over-year to $676000.0 in Q1 2026; TTM through Mar 2026 was $676000.0, a 111.91% increase from a year earlier, with the FY2025 full-year figure at $701000.0, up 133.67% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $676000.0, down from $701000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for SNWV reached as high as $701000.0 in Q4 2025 and fell as low as $205000.0 in Q3 2022.
- Historically, Non-Current Deffered Revenue has averaged $360764.7 across 5 years, with a median of $319000.0 in 2025.
- Across the five-year window, Non-Current Deffered Revenue declined 27.12% in 2023 and soared 133.67% in 2025, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $230000.0 in 2022, then surged by 50.87% to $347000.0 in 2023, then retreated by 13.54% to $300000.0 in 2024, then surged by 133.67% to $701000.0 in 2025, then dropped by 3.57% to $676000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $676000.0 in Q1 2026, $701000.0 in Q4 2025, and $575000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SANUWAVE Health | 18.65 Mn | 7.87 Mn | 7.43 Mn | 676,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 676,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Sep 30, 2025 | 575,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 358,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Mar 31, 2024 | 340,000.00 |
| Dec 31, 2023 | 347,000.00 |
| Sep 30, 2023 | 284,000.00 |
| Jun 30, 2023 | 215,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Dec 31, 2022 | 230,000.00 |
| Sep 30, 2022 | 205,000.00 |
| Jun 30, 2022 | 295,000.00 |
| Mar 31, 2022 | 303,000.00 |
| Dec 31, 2021 | 293,000.00 |
| Sep 30, 2021 | 230,000.00 |
| Jun 30, 2021 | 181,000.00 |